Literature DB >> 21103954

Association between C-281A and val66met functional polymorphisms of BDNF gene and risk of recurrent major depressive disorder in Polish population.

Renata Suchanek1, Aleksander Owczarek, Małgorzata Kowalczyk, Krzysztof Kucia, Jan Kowalski.   

Abstract

According to neurotrophic hypothesis, brain-derived neurotrophic factor (BDNF) is the potential candidate involved in the pathogenesis of depression. We examined the influence of C-281A (rs28383487) and val66met (rs6265) functional polymorphisms in BDNF gene on vulnerability to major depressive disorder, recurrent (MDD-R), in a Caucasian population. To our knowledge, this is the first case-control study to examine C-281A polymorphism in MDD-R. Genetic studies assessing the relationship between val66met polymorphism and major depression have yielded ambiguous results. We conducted a comparison of allele and genotype frequencies between 116 in-patients with MDD-R and 218 healthy subjects. Analyses were performed for whole groups as well as according to sex. Haplotype analysis was also performed. The polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique was used for genotyping of single nucleotide polymorphisms (SNPs). C-281A and val66met polymorphisms are in a linkage disequilibrium (LD). This study failed to find an association between C-281A polymorphism with MDD-R, but such an association was found in the case of val66met polymorphism. The val/val genotype was more frequent in depressed individuals compared to the control group, both in total analysis and after stratification by sex. The val allele is connected with a higher risk of MDD-R development in men than in women. Correspondence analysis has shown that the co-presence of genotypes val/val and C/C is connected with a higher risk of MDD-R development (odds ratio [OR]=2.05, p<0.01) compared to other genotype combinations in both analysed SNPs. Haplotype analysis has shown a significantly lower frequency of met-C haplotype in depressed individuals compared to the control group.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21103954     DOI: 10.1007/s12031-010-9478-y

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  37 in total

Review 1.  Estrogen actions throughout the brain.

Authors:  Bruce McEwen
Journal:  Recent Prog Horm Res       Date:  2002

Review 2.  A neurotrophic model for stress-related mood disorders.

Authors:  Ronald S Duman; Lisa M Monteggia
Journal:  Biol Psychiatry       Date:  2006-04-21       Impact factor: 13.382

Review 3.  Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegenerative disorders.

Authors:  Hymie Anisman; Zul Merali; Shawn Hayley
Journal:  Prog Neurobiol       Date:  2008-02-13       Impact factor: 11.685

Review 4.  Neurotrophin signalling in health and disease.

Authors:  Moses V Chao; Rithwick Rajagopal; Francis S Lee
Journal:  Clin Sci (Lond)       Date:  2006-02       Impact factor: 6.124

5.  BDNF variation and mood disorders: a novel functional promoter polymorphism and Val66Met are associated with anxiety but have opposing effects.

Authors:  Xueying Jiang; Ke Xu; Joelle Hoberman; Feng Tian; Aimee J Marko; Juwaria F Waheed; Claudia R Harris; Ann M Marini; Mary-Anne Enoch; Robert H Lipsky
Journal:  Neuropsychopharmacology       Date:  2005-07       Impact factor: 7.853

6.  BDNF Val66Met polymorphism is associated with HPA axis reactivity to psychological stress characterized by genotype and gender interactions.

Authors:  Idan Shalev; Elad Lerer; Salomon Israel; Florina Uzefovsky; Inga Gritsenko; David Mankuta; Richard P Ebstein; Marsha Kaitz
Journal:  Psychoneuroendocrinology       Date:  2008-11-05       Impact factor: 4.905

7.  Association study of brain-derived neurotrophic factor in adults with a history of childhood onset mood disorder.

Authors:  J Strauss; C L Barr; C J George; N King; S Shaikh; B Devlin; M Kovacs; J L Kennedy
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2004-11-15       Impact factor: 3.568

8.  The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function.

Authors:  Michael F Egan; Masami Kojima; Joseph H Callicott; Terry E Goldberg; Bhaskar S Kolachana; Alessandro Bertolino; Eugene Zaitsev; Bert Gold; David Goldman; Michael Dean; Bai Lu; Daniel R Weinberger
Journal:  Cell       Date:  2003-01-24       Impact factor: 41.582

9.  Allelic differences in the brain-derived neurotrophic factor Val66Met polymorphism in late-life depression.

Authors:  Warren D Taylor; Stephan Züchner; Douglas R McQuoid; David C Steffens; Marcy C Speer; K Ranga R Krishnan
Journal:  Am J Geriatr Psychiatry       Date:  2007-10       Impact factor: 4.105

10.  The brain-derived neurotrophic factor rs6265 (Val66Met) polymorphism and depression in Mexican-Americans.

Authors:  Luciana Ribeiro; João V Busnello; Rita M Cantor; Fiona Whelan; Pamela Whittaker; Panos Deloukas; Ma-Li Wong; Julio Licinio
Journal:  Neuroreport       Date:  2007-08-06       Impact factor: 1.837

View more
  6 in total

1.  BDNF Val66Met and cognition: all, none, or some? A meta-analysis of the genetic association.

Authors:  S D Mandelman; E L Grigorenko
Journal:  Genes Brain Behav       Date:  2011-12-05       Impact factor: 3.449

2.  Association study between BDNF C-281A polymorphism and paranoid schizophrenia in Polish population.

Authors:  Renata Suchanek; Aleksander Owczarek; Jan Kowalski
Journal:  J Mol Neurosci       Date:  2011-06-28       Impact factor: 3.444

3.  Brain-derived neurotrophic factor gene polymorphisms, neurotransmitter levels, and depressive symptoms in an elderly population.

Authors:  Maria E Czira; Heike Wersching; Bernhard T Baune; Klaus Berger
Journal:  Age (Dordr)       Date:  2011-09-07

4.  Brain-derived neurotrophic factor serum levels and genotype: association with depression during interferon-α treatment.

Authors:  Francis E Lotrich; Salwa Albusaysi; Robert E Ferrell
Journal:  Neuropsychopharmacology       Date:  2012-12-18       Impact factor: 7.853

5.  Genetic Role of BDNF Val66Met and 5-HTTLPR Polymorphisms on Depressive Disorder.

Authors:  Kyu Young Lee; Seong Hoon Jeong; Se Hyun Kim; Yong Min Ahn; Yong Sik Kim; Hee Yeon Jung; Yang Weon Bang; Eun-Jeong Joo
Journal:  Psychiatry Investig       Date:  2014-04-11       Impact factor: 2.505

6.  Mechanisms of extracellular signal-regulated kinase/cAMP response element-binding protein/brain-derived neurotrophic factor signal transduction pathway in depressive disorder.

Authors:  Hongyan Wang; Yingquan Zhang; Mingqi Qiao
Journal:  Neural Regen Res       Date:  2013-03-25       Impact factor: 5.135

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.